Market revenue in 2023 | USD 189.0 million |
Market revenue in 2030 | USD 266.5 million |
Growth rate | 5% (CAGR from 2023 to 2030) |
Largest segment | Soil-transmitted helminthiases |
Fastest growing segment | Chagas disease |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dengue, Chikungunya, Rabies, Leprosy, Buruli ulcer, Yaws, Lymphatic Filariasis, Taeniasis/Cysticercosis, Foodborne Trematode Infections, Echinococcosis, Chagas disease, Dracunculiasis, Human African Trypanosomiasis (sleeping sickness), Soil-transmitted Helminthiases, Onchocerciasis, Schistosomiasis, Scabies and Other Ecoparasites, Snakebite Envenoming, Leishmaniases |
Key market players worldwide | Roche, Abbott Laboratories, Thermo Fisher Scientific Inc, Eurobio-Scientific, Omega Laboratories, Avacta Group PLC, Oscar Health Inc Class A, ZeptoMetrix, InBios, DiaSys Diagnostic Systems |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to neglected tropical diseases diagnosis market will help companies and investors design strategic landscapes.
Soil-transmitted helminthiases was the largest segment with a revenue share of 10.05% in 2023. Horizon Databook has segmented the Malaysia neglected tropical diseases diagnosis market based on dengue, chikungunya, rabies, leprosy, buruli ulcer, yaws, lymphatic filariasis, taeniasis/cysticercosis, foodborne trematode infections, echinococcosis, chagas disease, dracunculiasis, human african trypanosomiasis (sleeping sickness), soil-transmitted helminthiases, onchocerciasis, schistosomiasis, scabies and other ecoparasites, snakebite envenoming, leishmaniases covering the revenue growth of each sub-segment from 2018 to 2030.
Malaysia has a high prevalence of various NTDs, such as rabies, dengue, and lymphatic filariasis. Of vector-borne diseases, dengue is the greatest threat in the country. According to WHO, in Malaysia, around 88,000 new cases and more than 140 deaths were recorded due to dengue in 2020.
NTDs, such as rabies and lymphatic filariasis, are endemic in various parts of Malaysia. Sarawak reported 31 cases of rabies in humans between July 2017 and December 2020, of which 29 died.
To control and eradicate NTDs, the Malaysian government undertook various initiatives, such as awareness programs, mass vaccination, and Global Programme to Eliminate Lymphatic Filariasis. These factors are expected to propel market growth over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Malaysia neglected tropical diseases diagnosis market , including forecasts for subscribers. This country databook contains high-level insights into Malaysia neglected tropical diseases diagnosis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account